Prosecution Insights
Last updated: April 19, 2026

Smith Patent, LLC

12 pending office actions • 9 clients

Portfolio Summary

12
Total Pending OAs
5
Final Rejections
7
Non-Final OAs

Client Portfolio (9 clients)

Client (Assignee)Pending OAs
Albert-Ludwigs-Universität Freiburg 3
Mariposa Technology, Inc. 1
Enzymaster (Ningbo) Bio-Engineering Co., Ltd. 1
Makous Research, LLC 1
Midas Pharma GmbH 1
Ioniq Skincare GmbH & Co. Kg 1
University College London 1
Luye Pharma Switzerland AG 1
Tillotts Pharma AG 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19283009 SYNTHETIC TISSUE MODELS, MATERIALS, AND METHODS FOR THERMAL TREATMENT TRAINING AND SIMULATION Unknown POLLOCK, ZACHARY JOSEPH 3715 Non-Final OA Jul 28, 2025
18753352 Spectroscopic Methods and Systems for the Qualitative and Quantitative Analysis of Samples Mariposa Technology, Inc. TON, TRI T 2877 Non-Final OA Jun 25, 2024
18711814 BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF PREGABALIN INTERMEDIATES Enzymaster (Ningbo) Bio-Engineering Co., Ltd. HOLLAND, PAUL J 1656 Non-Final OA May 20, 2024
18657444 Methods, Systems, Devices and Components for the Treatment of Stroke in a Patient with Interferential Cranial Electrical Stimulation Makous Research, LLC MUTCHLER, CHRISTOPHER JOHN 3796 Non-Final OA May 07, 2024
18559440 LOSARTAN-CONTAINING MICRO TABLET FOR PEDIATRIC APPLICATIONS Midas Pharma GmbH TRAN, SUSAN T 1615 Non-Final OA Nov 07, 2023
18282896 ELECTROSTATICALLY SPRAYABLE TANNING FORMULATION Ioniq Skincare GmbH & Co. Kg WRIGHT, SARAH C 1619 Final Rejection Sep 19, 2023
18333223 TOPICAL TREATMENT OF INFLAMMATORY BOWEL DISEASE USING ANTIBODIES AND FRAGMENTS THEREOF University College London ROONEY, NORA MAUREEN 1641 Final Rejection Jun 12, 2023
17794886 TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING THE INGREDIENT ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVE Luye Pharma Switzerland AG MERCIER, MELISSA S 1615 Non-Final OA Mar 29, 2023
17770272 AN UNBIASED IN VITRO ASSAY TO PROFILE OFF-TARGET ACTIVITY OF ONE OR MORE TARGET-SPECIFIC PROGRAMMABLE NUCLEASES IN CELLS (ABNOBA-SEQ) Albert-Ludwigs-Universität Freiburg VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 Final Rejection Apr 19, 2022
17634124 METHOD FOR DIAGNOSING BREAST CANCER Albert-Ludwigs-Universität Freiburg SCHLOOP, ALLISON ELIZABETH 1683 Final Rejection Feb 09, 2022
17298337 TOPICAL TREATMENT OF IMMUNE CHECKPOINT INHIBITOR INDUCED DIARRHOEA, COLITIS OR ENTEROCOLITIS USING ANTIBODIES AND FRAGMENTS THEREOF Tillotts Pharma AG BUTTICE, AUDREY L 1647 Final Rejection May 28, 2021
17255546 CHIMERIC ANTIGEN RECEPTORS THAT BIND TO PROSTATE SPECIFIC MEMBRANE ANTIGEN Albert-Ludwigs-Universität Freiburg EDGINGTONGIORDANO, FRANCESCA 1643 Non-Final OA Dec 23, 2020

Managing Smith Patent, LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month